|
TTC27 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.51689999958482E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.64995999999418E-05 |
| Normal-vs-Stage2 |
8.428900E-04 |
| Normal-vs-Stage3 |
1.82386999999506E-05 |
| Normal-vs-Stage4 |
1.25859999999811E-06 |
| Stage1-vs-Stage2 |
2.858400E-01 |
| Stage1-vs-Stage3 |
4.921400E-01 |
| Stage1-vs-Stage4 |
1.897840E-01 |
| Stage2-vs-Stage3 |
5.004800E-01 |
| Stage2-vs-Stage4 |
7.391800E-01 |
| Stage3-vs-Stage4 |
5.730000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.59024999999424E-05 |
| Normal-vs-AfricanAmerican |
6.084800E-03 |
| Normal-vs-Asian |
1.480840E-01 |
| Caucasian-vs-AfricanAmerican |
8.624400E-01 |
| Caucasian-vs-Asian |
1.692000E-02 |
| AfricanAmerican-vs-Asian |
1.775760E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.68709999998273E-06 |
| Normal-vs-Female |
9.99539999990695E-07 |
| Male-vs-Female |
7.317400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.379400E-04 |
| Normal-vs-Age(41-60Yrs) |
1.08690000000244E-07 |
| Normal-vs-Age(61-80Yrs) |
3.6894000000065E-05 |
| Normal-vs-Age(81-100Yrs) |
7.290200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.300300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.810030E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.327600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.001200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.500000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.883400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.731600E-01 |
| Classical-VS-Follicular |
2.79089999999371E-06 |
| Classical-VS-Other |
6.564500E-02 |
| Classical-VS-Normal |
5.373800E-04 |
| Tall-VS-Follicular |
1.603900E-04 |
| Tall-VS-Other |
4.706200E-02 |
| Tall-VS-Normal |
2.021800E-02 |
| Follicular-VS-Other |
8.437600E-01 |
| Follicular-VS-Normal |
4.27790025625541E-10 |
| Other-VS-Normal |
1.422100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.54260000223761E-08 |
| Normal-vs-N1 |
1.208490E-04 |
| N0-vs-N1 |
3.500600E-01 |
|
|
